Changing the Drug Discovery Paradigm
The process of drug discovery and development has fundamentally remained unaltered for the last 30 years, despite the use of modern tools and technologies. A radically new approach is needed to effectively explore the opportunities provided by the wealth of biomedical data to enable the development of new and effective treatments. Stratified Medical integrates leading edge predictive analytics, visualisation tools and machine learning to enable experienced drug hunters to explore huge, highly interconnected biomedical knowledge spaces in innovative and unprecedented ways. Stratified Medical is also committed to helping the biomedical community to better access and utilise scientific data by making tools available to the community for example ferret.
Jackie Hunter is the Chief Executive Officer of Stratified Medical. Stratified Medical unites traditional pharmaceutical development methodology with Artificial Intelligence to augment the research capabilities of its drug scientists so that they can gain new insights to increase the efficiency of medicines development. Jackie has over thirty years of experience in the bioscience research sector, working across academia and industry including leading neurology and gastrointestinal drug discovery and early childhood development for GlaxoSmithKline. She founded OI Pharma Partners in 2010 to support the life science sector in harnessing the power of open innovation and most recently was chief executive of the Biotechnology and Biological Sciences Research Council. She holds a personal chair from St George's Hospital Medical School, which was awarded in recognition of her contribution to bioscience research. In 2010 she was awarded a CBE in the Queen's Birthday Honours list for Services to the Pharmaceutical Industry.